| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Nov 13, 2025 | EXELIXIS, INC. | Director | Sell | 17.5 | -100,000 | -7.76% | ✗ | $4.4M |
| May 15, 2025 | May 16, 2025 | EXELIXIS, INC. | Director | Sell | 17.5 | -36,508 | -1.41% | ✗ | $1.6M |
| May 20, 2024 | May 22, 2024 | EXELIXIS, INC. | Director | Sell | 32.5 | -11,437 | -0.90% | ✗ | $240.2K |
| Feb 22, 2022 | Feb 24, 2022 | EXELIXIS, INC. | Director | Sell | 17.5 | -84,515 | -6.48% | ✗ | $1.7M |
| May 11, 2021 | May 13, 2021 | EXELIXIS, INC. | Director | Sell | 30.0 | -20,770 | -0.55% | ✗ | $518.8K |
| May 8, 2020 | May 8, 2020 | EXELIXIS, INC. | Director | Sell | 17.5 | -45,000 | -4.10% | ✗ | $1.2M |
| Feb 21, 2019 | Feb 22, 2019 | EXELIXIS, INC. | Director | Sell | 20.0 | -26,250 | -2.46% | ✗ | $557.8K |
| May 7, 2018 | May 7, 2018 | EXELIXIS, INC. | Director | Sell | 20.0 | -15,000 | -1.43% | ✗ | $332.3K |
| Mar 2, 2018 | Mar 2, 2018 | EXELIXIS, INC. | Director | Sell | 20.0 | -15,000 | -1.43% | ✗ | $360.8K |
| Sep 22, 2017 | Sep 22, 2017 | EXELIXIS, INC. | Director | Sell | 30.0 | -10,000 | -0.96% | ✗ | $254K |
| Sep 18, 2017 | Sep 20, 2017 | EXELIXIS, INC. | Director | Sell | 16.3 | -200,000 | -16.07% | ✗ | $5.5M |
| Mar 20, 2017 | Mar 21, 2017 | EXELIXIS, INC. | Director | Sell | 32.5 | -10,000 | -0.80% | ✗ | $216.6K |
| Jul 27, 2015 | Jul 27, 2015 | BIOGEN INC. | Director | Buy | 100.0 | +10,000 | 60.31% | ✗ | $3M |